Reducing stem cell variability with automation for standardized treatments: an interview with NYSCF's Scott Noggle
In this interview, Scott Noggle, Senior Vice President of Research at the New York Stem Cell Foundation Research Institute discusses why he is fascinated by stem cells and why variability in their production has hampered efforts to find new treatments.
Please sign in or register for FREE
Sign in to RegMedNet
Not yet a member? Become a member FREE to:
- Get unlimited access to ALL CONTENT
- Read selected articles from journals such as Regenerative Medicine FREE
- Receive a weekly email roundup of the latest news and expert opinions
Did you know?
Your RegMedNet account also gives you access to communities on drug discovery, real-world evidence and 3D printing in medicine. Find out more>>